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Dear Editor 
Both polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have been associated with an 
increased future risk of cardiovascular disease (1). However, it remains uncertain whether this is a 
consequence of inflammatory disease or relates to a common underlying mechanism. Retinal 
vascular images are a sensitive measures of vascular health, which are emerging as important 
biomarkers of future cardiovascular risk with changes affecting arterioles and venules (2). In this 
study, we assess whether vasculometric features associated with CVD are detectable prior to the 
onset of PMR and GCA.  
We analysed data from initially healthy subjects enrolled in the EPIC-Norfolk Study, a prospective 
population-based cohort which enrolled participants between the years 1993 to 1997 (3, 4). Digital 
photographs of the retinal fundus were taken of 8,112 participants between 2004 and 2011 using a 
TRC-NW6S non-mydriatic retinal camera and IMAGEnet Telemedicine System (Topcon Corporation, 
Tokyo, Japan) with a 10 megapixel Nikon D80 camera (Nikon Corporation, Tokyo, Japan). Retinal 
vessel widths were measured using the QUARTZ  (QUantitative Analysis of Retinal vessel Topology 
and siZe) programme (5). The fully automated algorithm uses an ensemble classifier of bagged 
decision trees to allocate vessels into arterioles and venules at 80% probability and calculates 
summary measures for each participant with an averaged measure between right and left eyes.  
Cases of PMR and GCA were identified by three methods: (i) free text questionnaire responses at 
enrolment, and thereafter, 18 months, 3, 10 and 13 years; (ii) linkage to hospital electronic discharge 
summaries containing ICD codes (iii) linkage to key word searches (polymyalgia or rheumatica or 
giant or arteritis) of out-patient clinic letters. To be identified as PMR or GCA, participants were 
required to have received at least two prescriptions for oral glucocorticoids within six months 
following their diagnosis. This approach follows classification methodology validated in the Clinical 
Practice Research Datalink (CPRD) (6). Cases were excluded from analysis if the diagnosis in the case 
record was refuted or changed within the first six months. Case assignment was carried out 
independently by two rheumatologists (MY, RW). Only incident cases with retinal images captured 
before their PMR or GCA diagnosis were included. 
Amongst 5,532 participants who had retinal images analysable by QUARTZ, we identified 30 cases of 
incident PMR (median age at diagnosis: 74.8 years, range [60.5, 87.0]; mean ESR at diagnosis: 48 
mm/hr; 70.0% female) and an additional 16 cases of GCA (median age at diagnosis: 75.0 years, range 
[62.1, 84.0]; mean ESR at diagnosis: 80 mm/hr; 81.3% female). Vasculometric measures of those 
subsequently developing PMR (Table1), showed wider venules compared to controls (5.5 microns 
increased width 95% CI 1.7 to 9.3, p=0.004), which remained significant after adjustment for age at 
time of retinal image capture, and sex (4.4 microns wider, 95% CI 0.7 to 8.2, p=0.021). Some who 
were diagnosed with disease did not meet the classification criteria. A stronger association was 
present when the analysis was limited to those cases which fulfilled current classification criteria 
sets. Although, on average those subsequently developing GCA had wider venules compared to 
controls (93 microns vs 91.1 microns) the difference failed to reach statistical difference. There was 
no association between arteriolar measures for either PMR or GCA.  
Using a novel retinal marker in a longitudinal population-based setting, this analysis shows that 
participants who developed PMR already had wider retinal venules prior to the onset of their 
inflammatory disease. The data are limited by the relatively small number of cases with incident 
disease and need to be replicated in other settings. They nevertheless lend weight to the hypothesis 
that vascular changes precede the onset of PMR.  
Table 1. Retinal vasculometric characteristics and their association to diagnoses of PMR and GCA  
 
Incident cases† Incident cases meeting 
classification sets 
Control n=5,477 
PMR (n) 30 24 
 
Venular width (μm) and SD 96.6 SD 12.5 100.0 SD 11.3 91.1 SD 10.6 from 5,036 controls 
Difference in venular width (μm) (95% CI) 80% 
probability* 
5.5 (1.7, 9.3) p=0.005 8.9 (4.7, 13.2) p=<0.001 
 
Adjusted for age at time of retinal 
photograph capture and sex 
4.4 (0.7, 8.2) p=0.021 7.8 (3.6, 12.0) p=<0.001  
    
Arteriolar width (μm) and SD 75.6 SD 7.6 76.9 SD 7.8 75.0 SD 6.3 from 5,037 controls 
Difference in arteriolar width (μm) (95% CI) 80% 
probability* 
0.7 (-1.6, 2.9) p=0.575 0.6 (-1.6, 2.9) p=0.57 
 
Adjusted for age at time of retinal 
photograph capture and sex 
1.0 (-1.2, 3.3) p=0.366 1.1 (-1.1, 3.4) p=0.32  
  
 
 
GCA (n) 16 13 
 
Venular width (μm) and SD 93.0 SD 9.4 93.7 SD 10.3 91.1 SD 10.6 from 5,036 controls 
Difference in venular width (μm) (95% CI) 80% 
probability* 
1.9 (-3.3, 7.1) p=0.47 2.6 (-3.2, 8.4) p=0.38 
 
Adjusted for age at time of retinal 
photograph capture and sex 
1.1 (-4.1, 6.2) p=0.68 1.5 (-4.2, 7.2) p=0.60  
    
Arteriolar width (μm) and SD 74.4 SD 5.9 73.8 SD 6.0 75.0 SD 6.3 from 5,037 controls 
Differences in arteriolar width (μm) (95% CI) 
80% probability* 
-0.6 (-3.6, 2.5) p=0.73 -1.2 (-4.7, 2.2) p=0.48 
 
Adjusted for age at time of retinal 
photograph capture and sex 
-0.03 (-3.1, 3.0) p=0.98 -0.7 (-4.1, 2.7) p=0.70  
    
SD – standard deviation.  * probability of vascular segment type (arteriole or venule) weighted by segment length, 95% CI – 95% confidence interval †incident cases – median time period 2.9 
years between retinal image capture and subsequent diagnosis with >75% having an interval of greater than 1 year.
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